COMPOUNDS AS GABA MODULATORS AND ASSOCIATED COMPOSITION

AR135256A2Pending Publication Date: 2026-08-05SAGE THERAPEUTICS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
ARP20250100383
Authority / Receiving Office
AR · AR
Patent Type
Applications
Current Assignee / Owner
Priority Date
2018-11-02
Filing Date
2025-02-13
Publication Date
2026-08-05
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.

Claims

Compounds of formula (II) and their pharmaceutically acceptable salts, wherein t, R7, R3, R9, R6a, R6b, R11a, R11b, R15a, R15b, R16a, R16b, R17a, R17b, R18a, R18b, R19a, R19b, R5a, R5b, R8, and R13 have the values ​​defined in the explanatory memorandum. Pharmaceutical compositions comprising a compound of formula (II) and methods for using the compounds, for example, in the treatment of disorders related to the central nervous system.